Handelsavisen
prelaunch
Companies Financials LFT
LF
LFT NYSE Banks

Lument Finance Trust, Inc.

$0,69
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
35,9M USD
P/E
EV / Rev
Div yield
33,34 %
Op margin
ROE
0,1 %
Net margin
Debt / equity
Beta
52w range
Volume
Day range
Prev close
$0,66
Open
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

Lument Finance Trust, Inc. operates as a commercial bank specializing in commercial mortgage loans held-for-investment, generating revenue primarily through net interest income from its loan portfolio.

Business. Lument Finance Trust, Inc. (NYSE: LFT) is a financial services company operating within the commercial banking industry. The firm generates revenue primarily through interest income, consistent with standard banking operations. Specific details regarding operating segments and geographic distribution are not provided in the available data. The company is headquartered in the United States and is listed on the New York Stock Exchange.

Classification96 %
SectorFinancials
Business sectorBanking & Investment Services
Industry groupBanking Services
IndustryBanks
ActivityCommercial Banks
Generated · model-assisted
Sell-side consensus
HOLD2 analysts
0 buy2 hold0 sell
Avg 12m price target2,50

Analyst recommendations

2 analysts · consensus Hold
Buy0
Hold2
Sell0
12-month price target
2,50
Consensus of sell-side coverage.
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Hold
2 analysts · indicative
Ownership
Geode Capital Management, L.L.C.
largest disclosed fund holder
Profitability
0,1 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning LFT.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials · THIS SECTOR−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to LFT. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Peers
    • DividendDividend USD 1.75/sh2026-09-25 · Bank of America (BAC)
    • EarningsQ3 2026 earnings (expected)2026-10-13 · estimated · JPMorgan Chase (JPM)
    • EarningsQ3 2026 earnings (expected)2026-10-13 · estimated · Citigroup (C)
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Lument Finance Trust, Inc. (NYSE: LFT) is a financial services company operating within the commercial banking industry. The firm generates revenue primarily through interest income, consistent with standard banking operations. Specific details regarding operating segments and geographic distribution are not provided in the available data. The company is headquartered in the United States and is listed on the New York Stock Exchange.

    Classification96 %
    SectorFinancials
    Business sectorBanking & Investment Services
    Industry groupBanking Services
    IndustryBanks
    ActivityCommercial Banks
    AI synthesis
    GENERATED

    Lument Finance Trust maintains a capital structure characterized by high leverage typical of the banking sector, with total liabilities of $988.8 million against total equity of $216.0 million. The valuation snapshot indicates a price-to-book ratio of 0.27, suggesting the market values the company at a significant discount to its tangible book value. Liquidity is assessed as low, with cash and equivalents standing at $21.2 million, which is modest relative to the $1.2 billion total asset base. The debt-to-equity ratio is reported as 0.0 in the computed snapshot, likely reflecting the classification of securitized debt obligations and secured financing agreements as liabilities rather than traditional corporate debt, though the balance sheet shows substantial secured financing arrangements.

    Profitability metrics are extremely compressed, with a return on equity of 0.001 and return on assets of 0.0002 for the latest period. Net income attributable to common stockholders was negative $978,375 in Q1 2026, driven by preferred stock dividends of $1.18 million that exceeded the consolidated net income of $206,583. The price-to-earnings ratio of 280.29 is distorted by the minimal earnings base. Operating expenses increased to $3.66 million from $2.59 million in the prior year period, partly due to a $1.35 million real estate owned impairment expense and a $1.15 million loss on extinguishment of debt.

    The company’s revenue is concentrated in commercial mortgage loans held-for-investment, which generated $20.9 million in interest income in Q1 2026. The investment guidelines specify fully funded principal balances generally between $5 million and $75 million, with loan-to-value ratios up to 85% of as-is value. Geographic and segment data beyond the primary commercial mortgage focus is not detailed in the available segments, indicating a highly concentrated business model reliant on the performance of this specific loan type.

    Growth trajectory shows a decline in net interest income, which fell to $5.70 million in Q1 2026 from $7.73 million in Q1 2025. This contraction is attributed to lower interest income from commercial mortgage loans and increased interest expense from secured financing agreements, which rose from zero to $3.86 million year-over-year. The release of credit losses provided a $732,373 benefit in Q1 2026, contrasting with a $5.70 million provision in the prior year, indicating a temporary stabilization in credit quality metrics.

    Risk assessment highlights medium dilution risk and low liquidity. Key flags indicate source documents mention dilution or offering risk, consistent with the company’s history of equity issuances to fund operations. The company faces significant listing compliance risk, having closed below $1.00 for 24 consecutive trading days, approaching the 30-day deficiency threshold for NASDAQ minimum bid price requirements. The last recorded close was $0.68, well below the $1.00 minimum.

    Recent filings reveal a complex financing environment, with the company utilizing collateralized loan obligations, secured term loans, and repurchase agreements to fund its portfolio. The cash flow statement shows net cash provided by operating activities of $3.57 million, while financing activities used $14.81 million, primarily for dividend payments and debt repayments. Analyst sentiment is neutral, with a mean recommendation of 3.00 (Hold) and a mean price target of $2.50, implying significant upside from the current distressed price levels.

    Key takeaways
    • Net interest income declined 26% year-over-year to $5.70 million, pressuring profitability.
    • The company faces imminent NASDAQ delisting risk after trading below $1.00 for 24 consecutive days.
    • Return on equity is negligible at 0.001, with common shareholders absorbing a net loss of $978k.
    • Liquidity is constrained with only $21.2 million in cash against $988.8 million in liabilities.
    • Analysts maintain a Hold rating with a $2.50 price target, suggesting potential recovery if listing status is preserved.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 5

    Analysts project 187.4% upside to a $2.50 target price, significantly above the current $0.87 market price.

    The stock trades at a deep discount of 0.28x price-to-book, suggesting significant undervaluation relative to tangible book value.

    Net income surged 925% year-over-year to $22.6 million in FY2025, demonstrating strong recent profitability growth.

    Cash conversion of 17.28% ranks as best-in-class compared to the 1.14% median for the bank cohort.

    Equity grew 8.6% year-over-year to $237.8 million in FY2025, indicating expanding capital base despite asset contraction.

    BEAR CASE · 4

    Total assets declined 7.2% year-over-year to $1.13 billion in FY2025, signaling a shrinking balance sheet.

    Leverage band is classified as high with a debt-to-equity ratio of 4.55, indicating elevated financial risk.

    The company faces medium dilution risk, which could negatively impact existing shareholder value and earnings per share.

    Return on assets of 0.02% is extremely low, reflecting minimal profitability generated from the company's total asset base.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-03-31
    Q4 2025 · Quarter highlights
    Revenue
    Operating income
    Net income$206.6k
    Free cash flow
    EPS
    Operating cash flow$3.6M
    Financials
    Income statement
    Revenue
    Gross profit
    Operating income
    Net income$206.6k
    Balance sheet
    Total assets$1.20B
    Total liabilities$988.8M
    Total equity$216.0M
    Cash & equivalents$21.2M
    Long-term debt
    Cash flow
    Operating cash flow$3.6M
    CapEx
    Free cash flow
    SBC$52.5k

    Valuation FY

    Market price
    $0,69
    Market cap
    $57.9M
    Enterprise value
    $36.7M
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    10.3x
    P / B
    0.3x
    P / Tangible book
    0.3x
    Tangible book
    $216.1M
    Net cash
    $21.2M
    Current ratio
    Debt / equity
    ROA
    0.0%
    ROE
    0.1%
    Cash conversion
    1728.0%
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    -0.1%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    Business relationships16 disclosed relationships · 2 types · extracted from filings & disclosures
    Partners1
    OrixIX.OPartner95%Source ↗
    Subsidiaries15
    EX21:256e89976aefEX21:256e89976aefSubsidiarie97%
    EX21:300fa54572a1EX21:300fa54572a1Subsidiarie97%
    EX21:61e6a934524eEX21:61e6a934524eSubsidiarie97%
    EX21:7928b037a573EX21:7928b037a573Subsidiarie97%
    EX21:8432c87efec7EX21:8432c87efec7Subsidiarie97%
    EX21:8f53ec11f891EX21:8f53ec11f891Subsidiarie97%
    EX21:9bfdc8da8f9bEX21:9bfdc8da8f9bSubsidiarie97%
    EX21:b1f39e61938bEX21:b1f39e61938bSubsidiarie97%
    EX21:c124b97bcaceEX21:c124b97bcaceSubsidiarie97%
    EX21:d0412da4acbaEX21:d0412da4acbaSubsidiarie97%
    EX21:d30e4f264aceEX21:d30e4f264aceSubsidiarie97%
    EX21:d720bd27f970EX21:d720bd27f970Subsidiarie97%
    EX21:de9f49e3ecebEX21:de9f49e3ecebSubsidiarie97%
    EX21:e14d73da6c8bEX21:e14d73da6c8bSubsidiarie97%
    EX21:ef542818b0d5EX21:ef542818b0d5Subsidiarie97%

    Supply chain

    Vendors → LFT ↔ Partners → Customers · click any node to drill
    VENDORSPARTNERSCUSTOMERSLFTLFTLument Finance Trust, Inc.16 entitiesOrixBankingUS
    1 mention in 10-K0 from corporate websites0 from news dispatches
    Updated 2026-06-24

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    0,23
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    2
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-10 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate0,26
    Revenueno estimateno estimate82,9M USD
    Operating incomeno estimateno estimateno estimate
    Full-year consensus mean (period as reported by source) · consensus in USD. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution2 analysts
    Strong buy0
    Buy0
    Hold2
    Sell0
    Strong sell0
    12-month price target$2,50 · Median $2,50
    Low $2,50High $2,50
    EPS surprise
    −46,2 %
    reported vs consensus · miss
    Revenue surprise
    −4,7 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$2,50
    Mean$2,50
    Median$2,50
    High$2,50
    Spot$0,69
    +265.0 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskMedium
    Liquidity riskLow
    Filing-based flags
    • Source documents mention dilution or offering risk.

    Benchmarks vs cohort

    ROE0,1 %Bottom quartile
    D/E0,00Above median
    Cash Conv17,28Best in class

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Regulatory filings
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    • Reference data
    How metrics are computed
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Return On Equity
      net_income / total_equity
    • Market Cap
      market_price * shares_outstanding_diluted
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    Source documents
    • Lument Finance Trust, Inc. company facts · 2026-08-03
    • Lument Finance Trust, Inc. 10-Q 2026-05-15 · 2026-08-03
    • Lument Finance Trust, Inc. 10-K 2026-03-23 · 2026-08-03
    • Lument Finance Trust, Inc. 10-Q 2025-11-12 · 2026-08-03
    • Lument Finance Trust, Inc. 10-Q 2025-08-08 · 2026-08-03
    • ha_price_listing fired on LFT · 2026-08-03
    • Lument Finance Trust Inc Market data — analyst estimates · 2026-08-03
    • Lument Finance Trust Inc Market data — ESG · 2026-08-03

    Ownership & reference

    Top holders

    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$2M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$3M
    • AQR Capital Management, LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,00 %$0M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,00 %$0M
    • Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$1M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,00 %$0M
    • Invesco QQQ TrustFunds · as of 2026-03-310,00 %$0M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,00 %$0M
    • T. Rowe Price Associates, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • FMR LLCInstitutional Investor · as of 2026-03-310,00 %$0M

    Leadership

    • James Peter FlynnChairman of the Board, Chief Executive Officer

    Insider activity

    Net buying14 buys · 3 sellsnet $271K6 insiders · last 365d
    • Keenan Walter CDirector · common stockOther 12 222 @ $1,12$14K · 2026-05-26
    • Hunt James ChristopherDirector · common stockOther 22 222 @ $1,12$25K · 2026-05-26
    • Cummins Neil A.Director · Common StockOther 12 222 @ $1,12$14K · 2026-05-26
    • HOULIHAN WILLIAM ADirector · common stockBought 10 000 @ $1,19$12K · 2026-05-21
    • HOULIHAN WILLIAM ADirector · common stockBought 10 000 @ $1,14$11K · 2026-05-20
    • Hunt James ChristopherDirector · commonOther 10 528 @ $1,31$14K · 2026-03-30
    • Cummins Neil A.Director · Common StockOther 10 528 @ $1,31$14K · 2026-03-30
    • Keenan Walter CDirector · common stockOther 10 528 @ $1,31$14K · 2026-03-30
    • HOULIHAN WILLIAM ADirector · common stockBought 5 000 @ $1,30$6K · 2026-03-27
    • HOULIHAN WILLIAM ADirector · common stockBought 15 000 @ $1,29$19K · 2026-03-26
    • Keenan Walter CDirector · preferred stockSold 44 @ $19,42$854 · 2026-03-26
    • Keenan Walter CDirector · preferred stockSold 3 156 @ $19,70$62K · 2026-03-26
    • Keenan Walter CDirector · preferred stockBought 1 500 @ $19,50$29K · 2026-03-26
    • Keenan Walter CDirector · preferred stockSold 400 @ $19,50$8K · 2026-03-26
    • Keenan Walter CDirector · preferred stockBought 5 000 @ $19,63$98K · 2026-03-26
    • Keenan Walter CDirector · common stockBought 25 000 @ $1,46$36K · 2025-12-30
    • Keenan Walter CDirector · common stockBought 9 205 @ $1,49$14K · 2025-12-19
    • Keenan Walter CDirector · common stockBought 795 @ $1,50$1K · 2025-12-18
    • BRIGGS JAMES AChief Financial Officer · common stockBought 10 000 @ $1,61$16K · 2025-12-01
    • BRIGGS JAMES AChief Financial Officer · common stockBought 1 200 @ $1,62$2K · 2025-11-28
    • Flynn James PeterCEO · common stockBought 55 000 @ $1,60$88K · 2025-11-26
    • BRIGGS JAMES AChief Financial Officer · common stockBought 2 000 @ $1,60$3K · 2025-11-26
    • HOULIHAN WILLIAM ADirector · common stockBought 3 000 @ $1,59$5K · 2025-11-25
    • Hunt James ChristopherDirector · common stockOther 16 351 @ $1,53$25K · 2025-11-24
    • Cummins Neil A.Director · Common StockOther 8 992 @ $1,53$14K · 2025-11-24

    Short positioning

    404.6Kshares short-17.3% vs prior
    2.59days to cover
    29.5%short of daily vol
    5.0Kfails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    LFTCanonical
    NYSE · USD

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    What changed

    no material change vs prior analysis (walked 17 fields; 4 schema-expansion field(s) excluded)

    • Narrative— → —medium
    • Business summary— → —medium
    • Conclusion— → —medium
    • Key takeaways— → —medium
    vs prior analysis 66 days ago
    peak dispatch · —
    OSINT findings
    Dilution riskMedium
    Liquidity riskLow
    Source documents mention dilution or offering risk.
    Relationship graph
    LFTJPMBACCIX.OEX21:256EX21:300EX21:61eEX21:792EX21:843EX21:8f5Banks
    This companyPeerSectorPartnersSubsidiaries

    Evidence & claims

    From filings & derived data
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): 7.7%Derived (calculated)
    • Return on equity (FY 2025-12-31): -1.3%Derived (calculated)
    • Return on assets (FY 2025-12-31): -0.2%Derived (calculated)
    • Debt-to-equity (FY 2025-12-31): 4.55xDerived (calculated)
    • Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): -66.6%Derived (calculated)
    • EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -141.2%Derived (calculated)
    • EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): -141.2%Derived (calculated)
    • Net income (YoY) (2025-12-31 vs 2024-12-31): -112.1%Derived (calculated)
    • Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -62.8%Derived (calculated)
    • Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -7.9%Derived (calculated)
    • Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 11.9%Derived (calculated)
    • EPS (diluted) (annual): USD-PER-SHARES -0SEC XBRL filing
    • Total liabilities (annual): USD 996.89MSEC XBRL filing
    • Cash & equivalents (annual): USD 23.11MSEC XBRL filing
    • EPS (basic) (annual): USD-PER-SHARES -0SEC XBRL filing
    • Net income (annual): USD -2.75MSEC XBRL filing
    • Shareholders' equity (annual): USD 218.99MSEC XBRL filing
    • Operating cash flow (annual): USD 10.1MSEC XBRL filing
    • Shares outstanding (annual): 52.4MSEC XBRL filing
    • Total assets (annual): USD 1.22BSEC XBRL filing
    • Return on equity (FY 2024-12-31): 9.5%Derived (calculated)
    • Return on assets (FY 2024-12-31): 2.0%Derived (calculated)
    • Total liabilities (YoY) (2024-12-31 vs 2023-12-31): -26.2%Derived (calculated)
    • Cash & equivalents (YoY) (2024-12-31 vs 2023-12-31): 35.0%Derived (calculated)
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-08-02 22:31 UTCEVENTHa Price Listing LFT approaching NASDAQ minimum-bid deficiency: closed below $1.00 for 24 consecutive trading days (deficiency at 30). Last close $0.68.
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-12FILINGFORM 8-K →
    2026-05-26 00:00 UTCINSIDER5 insider transactions — 2026-05
    2026-05-26 00:00 UTCINSIDER5 insider transactions — 2026-05
    2026-05-26INSIDERKeenan Walter C transacted 12.2k sh — Director ~$14k
    2026-05-26INSIDERHunt James Christopher transacted 22.2k sh — Director ~$25k
    2026-05-26INSIDERCummins Neil A. transacted 12.2k sh — Director ~$14k
    2026-05-21INSIDERHOULIHAN WILLIAM A bought 10.0k sh — Director ~$12k
    2026-05-20FILINGFORM 8-K →
    2026-05-20INSIDERHOULIHAN WILLIAM A bought 10.0k sh — Director ~$11k
    2026-05-15FILING10-Q filing →
    2026-04-30FILINGDEF 14A filing →
    2026-03-31EARNINGSQuarterly results — Q4 2025 Net USD 0.2M
    2026-03-30 00:00 UTCINSIDER10 insider transactions — 2026-03 · net buy $124k
    2026-03-30 00:00 UTCINSIDER10 insider transactions — 2026-03 · net buy $124k
    2026-03-30INSIDERHunt James Christopher transacted 10.5k sh common — Director ~$14k
    2026-03-30INSIDERCummins Neil A. transacted 10.5k sh — Director ~$14k
    2026-03-30INSIDERKeenan Walter C transacted 10.5k sh — Director ~$14k
    2026-03-27INSIDERHOULIHAN WILLIAM A bought 5.0k sh — Director ~$6k
    2026-03-26INSIDERHOULIHAN WILLIAM A bought 15.0k sh — Director ~$19k
    2026-03-26INSIDERKeenan Walter C sold 44 sh preferred stock — Director ~$1k
    2026-03-26INSIDERKeenan Walter C sold 3.2k sh preferred stock — Director ~$62k
    2026-03-26INSIDERKeenan Walter C bought 1.5k sh preferred stock — Director ~$29k
    2026-03-26INSIDERKeenan Walter C sold 400 sh preferred stock — Director ~$8k
    2026-03-26INSIDERKeenan Walter C bought 5.0k sh preferred stock — Director ~$98k
    2026-03-23FILINGFORM 8-K →
    2026-03-23FILING10-K filing →
    2026-02-23FILINGFORM 8-K →
    2025-12-31EARNINGSQuarterly results — Q3 2025
    2025-12-31EARNINGSAnnual results — FY 2025 Net USD -2.7M
    2025-12-30 00:00 UTCINSIDER4 insider transactions — 2025-12
    2025-12-30 00:00 UTCINSIDER4 insider transactions — 2025-12
    2025-12-30INSIDERKeenan Walter C bought 25.0k sh — Director ~$36k
    2025-12-19INSIDERKeenan Walter C bought 9.2k sh — Director ~$14k
    2025-12-18INSIDERKeenan Walter C bought 795 sh — Director ~$1k
    2025-12-16FILINGFORM 8-K →
    2025-12-01INSIDERBRIGGS JAMES A bought 10.0k sh — Chief Financial Officer ~$16k
    2025-11-28 00:00 UTCINSIDER7 insider transactions — 2025-11 · net buy $150k
    Showing the 40 most recent of 55 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data · Reference data Premium coverage